• Home
  • News
  • Antimicrobial PICCs NEW WEBINAR from INS FREE for Members

Antimicrobial PICCs NEW WEBINAR from INS FREE for Members

Monday, March 30, 2020 1:18 PM | Chris Cavanaugh (Administrator)

Adding Antimicrobial PICCs: Making the Case and Measuring the Outcomes

This webinar is sponsored by Teleflex, where innovation inspires hope.

More than five million central vascular access devices (CVADs) are inserted in patients each year in the United States. It is estimated that at least 85% of hospitalized patients in the US receive intravenous medications to meet their therapeutic needs. Although CVADs provide a means by which patients receive life changing treatment, they can also pose a significant risk of complications, which may cause patients harm, increase morbidity, lengthen hospital stay, and add to health care costs.

Infusion industry partners invest significantly in research and development of new technologies in order to develop CVADs that may help mitigate the risk of complications. Can the technological design of a central vascular access device significantly limit the incidence of central line-associated bloodstream infection (CLABSI), catheter occlusion, fibrin sheath formation, and catheter-related thrombosis (CRT)?

This presentation will focus on CVADs with antimicrobial and antithrombogenic protection. Specifically, catheters with chlorhexidine bonded to the internal and external catheter surfaces will be explored. At the conclusion of this session, learners will have increased understanding of the effects of central vascular access devices (CVADS) with bonded chlorhexidine.

Course Details

Instructor: Michelle DeVries, BS, MPH, CIC, VA-BC

 Contact Hours: 1.0 

CRNI ® Recertification Units (RUs): 1.0

 April 8, 2020 @ 1:00pm ET

 INS members: FREE

 Nonmembers: $45

Powered by Wild Apricot Membership Software